The revival was on the back of therapies, including cardiac and
anti-diabetic, which grew by 19.5% and 9.7% respectively in October
(over September), according to data from research firm AIOCD Awacs.
Respiratory medicines showed marginal improvement at -6.6% in October
as against -10.5 % in September.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-pharmaceutical-market-posts-10-growth-in-october/articleshow/79241938.cms
Sunday, November 15, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment